Granules India Ltd. is a fully integrated pharmaceutical manufacturer. The Company manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) which are distributed in over 55 countries. Vacancy details: Department: QC,R&D Experience: 3-7 years Qualification: Msc,Bpharm,Mpharm,Be.B,tech Salary: Not Disclosed Job Description: Greeting from Granules …
Lincoln is proud of its manufacturing capabilities. We are really distinct and powerful when it comes to the production capacity. Set up in the year 1979, the manufacturing facility of Lincoln is based at Khatraj, Gujarat sharing the same dais as with the international standards. Another …
Biologics represent the cutting-edge of biomedical research, and biosimilars present an enormous opportunity to provide affordable access to these advanced therapies. Biosimilars are intended to increase patients’ access to biologics as they are priced lower than branded, novel biologics and may further lead to the competitive …
hares of Premier Energies gained on November 4 after its subsidiaries Premier Energies International and Premier Energies Photovoltaic received orders totaling Rs 560 crore from two major Independent Power Producers (IPPs) and others. The orders include Rs 513 crore for solar modules and Rs 47 crore for solar …
Sunvet Pharma Pvt. Ltd. have always performed like a responsible contender. We are counted as a prominent manufacturer of PCD Pharma, Dry & Liquid Injections for Humans & Veterinary, falling under the category of Lactam Dry Powder Injection, General Range Injection, Hormonal Injection and covering a …
Brokerages on the Street have taken a U-turn with their growth outlook for Cipla just a few days after the company released its July-September numbers. The culprit here is the surprise regulatory clearance of Cipla’s Goa manufacturing facility. The facility, poised to manufacture a key oncology …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
